Population
256 patients monitored from participants of a clinical trial of EV-A71 vaccine conducted during 2012-2013.
Design
Cohort
Follow-up
June 2013 to March 2014
Authors
Loading...
HA monitoring in EV-A71 vaccine trial may guide pediatric enterovirus surveillance; leaves open dedicated prospective etiology studies.
This study provides the first report on the epidemiological and etiological characteristics of herpangina in mainland China, highlighting the overlap in enterovirus serotypes with HFMD and supporting the development of a multivalent vaccine.
Yao et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: